EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Group B streptococcal infections in pregnancy and early life

Gygeria Manuel iD, Joy Twentyman, Kristen Noble, Alison J Eastman, David M Aronoff, Ravin Seepersaud, Lakshmi Rajagopal iD, Kristina M Adams Waldorf iD

Clinical Microbiology Reviews · 13.03.2025 · 38 (1)

DOI: 10.1128/cmr.00154-22 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.03.2025. Verfasst von Gygeria Manuel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcus agalactiae, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 386 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial infections with Group B Streptococcus (GBS) are an important cause of adverse outcomes in pregnant individuals, neonates, and infants. GBS is a common commensal in the genitourinary and gastrointestinal tracts and can be detected in the vagina of approximately 20% of women globally. GBS can infect the fetus either during pregnancy or vaginal delivery resulting in preterm birth, stillbirth, or early-onset neonatal disease (EOD) in the first week of life. The mother can also become infected with GBS leading to postpartum endometritis, and rarely, maternal sepsis. An invasive GBS infection of the neonate may present after the first week of life (late-onset disease, LOD) through transmission from caregivers, breast milk, and other sources. Invasive GBS infections in neonates can result in sepsis, pneumonia, meningitis, neurodevelopmental impairment, death, and lifelong disability. A policy of routine screening for GBS rectovaginal colonization in well-resourced countries can trigger the administration of intrapartum antibiotic prophylaxis (IAP) when prenatal testing is positive, which drastically reduces rates of EOD. However, many countries do not routinely screen pregnant women for GBS colonization but may administer IAP in cases with a high risk of EOD. IAP does not reduce rates of LOD. A global vaccination campaign is needed to reduce the significant burden of invasive GBS disease that remains among infants and pregnant individuals. In this narrative review, we provide a comprehensive overview of the global impact of GBS colonization and infection, virulence factors and pathogenesis, and current and future prophylactics and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcal InfectionsStreptococcus agalactiaePregnancy Complications, InfectiousHumansPregnancyFemaleInfant, NewbornInfectious Disease Transmission, Vertical

Stichwörter der Autor:innen

Group B StreptococcusbacteriacolonizationcovRcovSearly-onset diseasefetushemolysinlate-onset diseasemeningitisplacentapneumoniapregnancypreterm birthsepsis

Autor:innen und Institutionen

  • Department of Obstetrics & Gynecology, University of Washington, Seattle, Washington, USA.
  • Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Global Health, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Gygeria Manuel, Lakshmi Rajagopal, Kristina M Adams Waldorf

Förderung

  • NIAID NIH HHS
  • NICHD NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • NIH HHS
  • HHS | NIH | NIH Office of the Director (OD)

Zitieren

APA

Manuel, G., Twentyman, J., Noble, K., Eastman, A. J., Aronoff, D. M., Seepersaud, R., Rajagopal, L., & Adams Waldorf, K. M. (2025). Group B streptococcal infections in pregnancy and early life. Clinical Microbiology Reviews, 38(1). https://doi.org/10.1128/cmr.00154-22

Vancouver

Manuel G, Twentyman J, Noble K, Eastman AJ, Aronoff DM, Seepersaud R, et al. Group B streptococcal infections in pregnancy and early life. Clinical Microbiology Reviews. 2025;38(1). doi:10.1128/cmr.00154-22

BibTeX
@article{Manuel2025,
  author = {Manuel, Gygeria and Twentyman, Joy and Noble, Kristen and Eastman, Alison J and Aronoff, David M and Seepersaud, Ravin and Rajagopal, Lakshmi and Adams Waldorf, Kristina M},
  title = {Group B streptococcal infections in pregnancy and early life},
  journal = {Clinical Microbiology Reviews},
  year = {2025},
  volume = {38},
  number = {1},
  doi = {10.1128/cmr.00154-22}
}
Kostenlos starten →